Source: ChemMedChem. Unidade: ICB
Subjects: MICROBIOLOGIA, MYCOBACTERIUM TUBERCULOSIS, BACTÉRIAS GRAM-POSITIVAS, INFECÇÕES BACTERIANAS GRAM-POSITIVAS, COMPOSTOS ORGÂNICOS, CRISTALOGRAFIA QUÍMICA, BENZENO
ABNT
KIRKMAN, Tim et al. Fragment-Merging strategies with known pyrimidine scaffolds targeting dihydrofolate reductase from mycobacterium tuberculosis. ChemMedChem, 2023Tradução . . Disponível em: https://doi.org/10.1002/cmdc.202300240. Acesso em: 09 nov. 2024.APA
Kirkman, T., Tan, S. F., Chavez-Pacheco, S. M., Hammer, A., Abell, C., Tosin, M., et al. (2023). Fragment-Merging strategies with known pyrimidine scaffolds targeting dihydrofolate reductase from mycobacterium tuberculosis. ChemMedChem. doi:10.1002/cmdc.202300240NLM
Kirkman T, Tan SF, Chavez-Pacheco SM, Hammer A, Abell C, Tosin M, Anthony G. Coyne, Dias MVB. Fragment-Merging strategies with known pyrimidine scaffolds targeting dihydrofolate reductase from mycobacterium tuberculosis [Internet]. ChemMedChem. 2023 ;[citado 2024 nov. 09 ] Available from: https://doi.org/10.1002/cmdc.202300240Vancouver
Kirkman T, Tan SF, Chavez-Pacheco SM, Hammer A, Abell C, Tosin M, Anthony G. Coyne, Dias MVB. Fragment-Merging strategies with known pyrimidine scaffolds targeting dihydrofolate reductase from mycobacterium tuberculosis [Internet]. ChemMedChem. 2023 ;[citado 2024 nov. 09 ] Available from: https://doi.org/10.1002/cmdc.202300240